abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

このページは 日本語 では利用できません。English で表示されています

記事

2023年4月5日

著者:
B4Ukraine Coalition

Letter to AbbVie regarding its ongoing business activities in Russia

We write to you as B4Ukraine, a coalition of Ukrainian and international civil society organizations working to curtail the financial resources enabling the Russian invasion of Ukraine. In the spirit of respect for the fundamental rights of all people, the rules-based international order, and a prosperous global economy, we expect companies to demonstrate public support for the people, democracy, and territorial integrity of Ukraine, opposition to Russia’s war of aggression, and alignment with the UN Guiding Principles on Business and Human Rights (UNGPs).

We request an urgent dialogue regarding potential inconsistencies between AbbVie’s obligations under international humanitarian and human rights law and the company’s ongoing business operations and relationships in Russia that may contribute to, or be linked with, human rights harms...

While we understand that AbbVie claims that its reason for continuing operations in the country is providing essential goods, the ‘essentiality argument’ is under increasing scrutiny. For example, Professor Jeffrey Sonnenfeld of Yale University challenges these explanations by stating that the reasons are “misguided at best, cynical in the medium case, and outright deplorably misleading and deceptive”...

We seek to understand the status of AbbVie’s exposure to Russia and how AbbVie has conducted and continues to conduct heightened human rights due diligence, and how the findings of such a process has resulted in these continued business activities and relationships...

タイムライン

プライバシー情報

このサイトでは、クッキーやその他のウェブストレージ技術を使用しています。お客様は、以下の方法でプライバシーに関する選択肢を設定することができます。変更は直ちに反映されます。

ウェブストレージの使用についての詳細は、当社の データ使用およびクッキーに関するポリシーをご覧ください

Strictly necessary storage

ON
OFF

Necessary storage enables core site functionality. This site cannot function without it, so it can only be disabled by changing settings in your browser.

クッキーのアナリティクス

ON
OFF

When you access our website we use Google Analytics to collect information on your visit. Accepting this cookie will allow us to understand more details about your journey, and improve how we surface information. All analytics information is anonymous and we do not use it to identify you. Google provides a Google Analytics opt-out add on for all popular browsers.

Promotional cookies

ON
OFF

We share news and updates on business and human rights through third party platforms, including social media and search engines. These cookies help us to understand the performance of these promotions.

本サイトにおけるお客様のプライバシーに関する選択

このサイトでは、必要なコア機能を超えてお客様の利便性を高めるために、クッキーやその他のウェブストレージ技術を使用しています。